Literature DB >> 17671876

Neurobiological underpinnings of insight deficits in schizophrenia.

Mujeeb U Shad1, Matcheri S Keshavan, Carol A Tamminga, C Munro Cullum, Anthony David.   

Abstract

Impaired insight into illness is commonly observed across various psychiatric illnesses, but is most frequent in patients with schizophrenia. The clinical relevance and public health impact of poor insight is reflected by its close association with important clinical outcome measures, such as treatment non-adherence, lower psychosocial functioning, poor prognosis, involuntary hospitalization, and higher utilization of emergency services. Although the neurobiology of insight has not been determined, data from neurocognitive and a few structural imaging studies provide some understanding of the neurobiological underpinnings of insight function in schizophrenia. Using published and preliminary data, we propose a hypothetical model of insight that may help initiate neurobiological investigations in this complex area.

Entities:  

Mesh:

Year:  2007        PMID: 17671876     DOI: 10.1080/09540260701486324

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  27 in total

1.  Anosognosia in schizophrenia: hidden in plain sight.

Authors:  Douglas S Lehrer; Jennifer Lorenz
Journal:  Innov Clin Neurosci       Date:  2014-05

2.  Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.

Authors:  Philip Gerretsen; David D Pothier; Carolyn Falls; Maxine Armstrong; Thushanthi Balakumar; Hiroyuki Uchida; David C Mamo; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  Psychiatry Res       Date:  2017-02-13       Impact factor: 3.222

Review 3.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

4.  Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia.

Authors:  Philip Gerretsen; M Mallar Chakravarty; David Mamo; Mahesh Menon; Bruce G Pollock; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2012-01-03       Impact factor: 5.038

5.  Insight and psychosis: Functional and anatomical brain connectivity and self-reflection in Schizophrenia.

Authors:  Branislava Ćurčić-Blake; Lisette van der Meer; Gerdina H M Pijnenborg; Anthony S David; André Aleman
Journal:  Hum Brain Mapp       Date:  2015-10-15       Impact factor: 5.038

6.  Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: resting state functional connectivity.

Authors:  Philip Gerretsen; Mahesh Menon; David C Mamo; Gagan Fervaha; Gary Remington; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  Schizophr Res       Date:  2014-11-08       Impact factor: 4.939

7.  Help-negation and suicidal ideation: the role of depression, anxiety and hopelessness.

Authors:  Coralie J Wilson; Frank P Deane
Journal:  J Youth Adolesc       Date:  2009-12-02

8.  Beyond dopamine: functional MRI predictors of responsiveness to cognitive behaviour therapy for psychosis.

Authors:  Veena Kumari; Elena Antonova; Dominic Fannon; Emmanuelle R Peters; Dominic H Ffytche; Preethi Premkumar; Vinodkumar Raveendran; Christopher Andrew; Louise C Johns; Philip A McGuire; Steven Cr Williams; Elizabeth Kuipers
Journal:  Front Behav Neurosci       Date:  2010-02-12       Impact factor: 3.558

9.  The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.

Authors:  Martino Belvederi Murri; Mario Amore; Pietro Calcagno; Matteo Respino; Valentina Marozzi; Mattia Masotti; Michele Bugliani; Marco Innamorati; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Schizophr Bull       Date:  2016-04-11       Impact factor: 9.306

10.  Neurological basis of poor insight in psychosis: a voxel-based MRI study.

Authors:  Michael A Cooke; Dominic Fannon; Elizabeth Kuipers; Emmanuelle Peters; Steven C Williams; Veena Kumari
Journal:  Schizophr Res       Date:  2008-06-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.